4-Hydroperoxycyclophosphamide purged autologous bone marrow transplantation of relapsed, responding non-Hodgkin's lymphoma with granulocyte colony stimulating factor support results in reliable hematopoietic recovery

Prog Clin Biol Res. 1994:389:9-15.

Authors

D Biggs¹, E Stadtmauer, P Mangan, M Edelstein, W Powlis, G Buzby, D Magee, B Sachs, L Silberstein

Affiliation

¹ Bone Marrow Transplant Program, University of Pennsylvania Medical Center, Philadelphia.

PMID: 7535466

No abstract available

Publication types

Clinical Trial

MeSH terms

Adult
Bone Marrow Purging / methods*
Bone Marrow Transplantation* / adverse effects
Cyclophosphamide / analogs & derivatives*
Female
Granulocyte Colony-Stimulating Factor / therapeutic use*
Granulocytes
Humans
Leukocyte Count
Lymphoma, Non-Hodgkin / blood
Lymphoma, Non-Hodgkin / drug therapy
Lymphoma, Non-Hodgkin / therapy*
Male
Middle Aged
Platelet Count
Recurrence
Transplantation, Autologous

Substances

Granulocyte Colony-Stimulating Factor
Cyclophosphamide
perfosfamide